Raymond James & Associates Decreases Stake in NeoGenomics, Inc. (NASDAQ:NEO) – Ticker Report

Raymond James & Associates cut its holdings in NeoGenomics, Inc. (NASDAQ:NEO) by 29.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 68,373 shares of the medical research company’s stock after selling 28,593 shares during the quarter. Raymond James & Associates’ holdings in NeoGenomics were worth $2,118,000 as of its most recent SEC filing.
Several other institutional inve…

Original Source